Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection
Status:
Terminated
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
This study will examine whether 12 month treatment with entecavir(Baraclude®) has an effect
on changes of liver stiffness measurement (LSM) and of hyaluronan measurement in patients
with chronic hepatitis B infection.
Phase:
Phase 4
Details
Lead Sponsor:
RWTH Aachen University
Collaborators:
Hannover Clinical Trial Center GmbH Hannover Medical School